China BlueChemical Zukünftiges Wachstum
Future Kriterienprüfungen 1/6
China BlueChemical wird ein jährliches Gewinn- und Umsatzwachstum von 4.3% bzw. 2.1% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 4.5% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 7% betragen.
Wichtige Informationen
4.3%
Wachstumsrate der Gewinne
4.5%
EPS-Wachstumsrate
| Chemicals Gewinnwachstum | 47.1% |
| Wachstumsrate der Einnahmen | 2.1% |
| Zukünftige Eigenkapitalrendite | 7.0% |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | 21 Aug 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
China BlueChemical Ltd.'s (HKG:3983) Intrinsic Value Is Potentially 63% Above Its Share Price
Oct 29
China BlueChemical (HKG:3983) Seems To Use Debt Quite Sensibly
Sep 20Why Investors Shouldn't Be Surprised By China BlueChemical Ltd.'s (HKG:3983) Low P/E
Jul 02China BlueChemical's (HKG:3983) Upcoming Dividend Will Be Larger Than Last Year's
May 31Is China BlueChemical Ltd. (HKG:3983) Potentially Undervalued?
May 21China BlueChemical (HKG:3983) Shareholders Should Be Cautious Despite Solid Earnings
May 03China BlueChemical Ltd.'s (HKG:3983) Shares Lagging The Market But So Is The Business
Feb 22A Look At The Intrinsic Value Of China BlueChemical Ltd. (HKG:3983)
Jan 22Why China BlueChemical Ltd. (HKG:3983) Could Be Worth Watching
Jan 04China BlueChemical (HKG:3983) Seems To Use Debt Rather Sparingly
Oct 19Should You Think About Buying China BlueChemical Ltd. (HKG:3983) Now?
Sep 22Should You Be Adding China BlueChemical (HKG:3983) To Your Watchlist Today?
Aug 28China BlueChemical (HKG:3983) Could Easily Take On More Debt
Jun 23China BlueChemical (HKG:3983) Is Paying Out A Larger Dividend Than Last Year
May 28China BlueChemical (HKG:3983) Ticks All The Boxes When It Comes To Earnings Growth
May 06China BlueChemical Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Apr 20China BlueChemical's (HKG:3983) Returns On Capital Are Heading Higher
Mar 29At HK$2.08, Is It Time To Put China BlueChemical Ltd. (HKG:3983) On Your Watch List?
Jan 18There's Been No Shortage Of Growth Recently For China BlueChemical's (HKG:3983) Returns On Capital
Dec 16Why China BlueChemical Ltd. (HKG:3983) Could Be Worth Watching
Oct 19China BlueChemical (HKG:3983) Could Easily Take On More Debt
Sep 28We Like These Underlying Return On Capital Trends At China BlueChemical (HKG:3983)
Aug 24Is China BlueChemical Ltd. (HKG:3983) Potentially Undervalued?
Jul 18Here's Why China BlueChemical (HKG:3983) Has Caught The Eye Of Investors
Jun 20China BlueChemical (HKG:3983) Is Increasing Its Dividend To HK$0.18
May 30China BlueChemical (HKG:3983) Could Easily Take On More Debt
Apr 28Analysts Just Shipped A Notable Upgrade To Their China BlueChemical Ltd. (HKG:3983) Estimates
Apr 01There's Been No Shortage Of Growth Recently For China BlueChemical's (HKG:3983) Returns On Capital
Mar 05Here's Why I Think China BlueChemical (HKG:3983) Might Deserve Your Attention Today
Feb 07Is China BlueChemical (HKG:3983) A Risky Investment?
Dec 14China BlueChemical (HKG:3983) Might Have The Makings Of A Multi-Bagger
Nov 26Is There Now An Opportunity In China BlueChemical Ltd. (HKG:3983)?
Oct 19Is China BlueChemical (HKG:3983) A Risky Investment?
Sep 09A Look At The Fair Value Of China BlueChemical Ltd. (HKG:3983)
Aug 23Here's What's Concerning About China BlueChemical's (HKG:3983) Returns On Capital
Aug 05Here's Why I Think China BlueChemical (HKG:3983) Might Deserve Your Attention Today
Jul 16At HK$2.36, Is It Time To Put China BlueChemical Ltd. (HKG:3983) On Your Watch List?
Jun 28A Look At The Fair Value Of China BlueChemical Ltd. (HKG:3983)
May 24Investors Could Be Concerned With China BlueChemical's (HKG:3983) Returns On Capital
May 05Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 13,415 | 1,445 | N/A | 2,064 | 2 |
| 12/31/2025 | 13,290 | 1,327 | N/A | 2,013 | 2 |
| 12/31/2024 | 12,782 | 1,203 | N/A | 1,769 | 2 |
| 6/30/2024 | 12,821 | 1,353 | 1,461 | 2,049 | N/A |
| 3/31/2024 | 12,905 | 1,867 | 1,131 | 1,796 | N/A |
| 12/31/2023 | 12,990 | 2,382 | 801 | 1,544 | N/A |
| 9/30/2023 | 13,037 | 2,401 | 699 | 1,660 | N/A |
| 6/30/2023 | 13,084 | 2,421 | 598 | 1,776 | N/A |
| 3/31/2023 | 13,682 | 2,032 | 701 | 1,959 | N/A |
| 12/31/2022 | 14,279 | 1,643 | 803 | 2,142 | N/A |
| 9/30/2022 | 14,469 | 1,416 | 1,058 | 2,356 | N/A |
| 6/30/2022 | 14,659 | 1,189 | 1,313 | 2,569 | N/A |
| 3/31/2022 | 14,028 | 1,343 | 1,586 | 2,754 | N/A |
| 12/31/2021 | 13,398 | 1,498 | 1,859 | 2,939 | N/A |
| 9/30/2021 | 12,477 | 1,589 | 1,709 | 2,548 | N/A |
| 6/30/2021 | 11,556 | 1,681 | 1,560 | 2,158 | N/A |
| 3/31/2021 | 10,987 | 1,213 | 1,224 | 1,710 | N/A |
| 12/31/2020 | 10,417 | 745 | 888 | 1,263 | N/A |
| 9/30/2020 | 10,489 | 605 | 669 | 1,047 | N/A |
| 6/30/2020 | 10,561 | 464 | 450 | 832 | N/A |
| 3/31/2020 | 10,710 | 584 | 615 | 987 | N/A |
| 12/31/2019 | 10,858 | 703 | 780 | 1,143 | N/A |
| 9/30/2019 | 10,944 | 939 | 1,046 | 1,333 | N/A |
| 6/30/2019 | 11,030 | 1,175 | 1,311 | 1,523 | N/A |
| 3/31/2019 | 11,145 | 1,277 | 1,570 | 1,764 | N/A |
| 12/31/2018 | 11,260 | 1,379 | 1,828 | 2,004 | N/A |
| 9/30/2018 | 10,710 | 946 | 1,877 | 2,054 | N/A |
| 6/30/2018 | 10,161 | 512 | 1,926 | 2,104 | N/A |
| 3/31/2018 | 9,980 | 281 | N/A | 1,902 | N/A |
| 12/31/2017 | 9,800 | 50 | N/A | 1,699 | N/A |
| 9/30/2017 | 9,781 | 124 | N/A | 1,600 | N/A |
| 6/30/2017 | 9,763 | 199 | N/A | 1,500 | N/A |
| 3/31/2017 | 9,134 | -8 | N/A | 1,308 | N/A |
| 12/31/2016 | 8,504 | -216 | N/A | 1,115 | N/A |
| 9/30/2016 | 9,154 | -7 | N/A | 1,059 | N/A |
| 6/30/2016 | 9,804 | 201 | N/A | 1,003 | N/A |
| 3/31/2016 | 10,238 | 515 | N/A | 1,179 | N/A |
| 12/31/2015 | 10,672 | 830 | N/A | 1,354 | N/A |
| 9/30/2015 | 10,475 | 496 | N/A | 1,609 | N/A |
| 6/30/2015 | 10,279 | 163 | N/A | 1,865 | N/A |
| 3/31/2015 | 10,538 | 134 | N/A | 1,803 | N/A |
| 12/31/2014 | 10,797 | 105 | N/A | 1,742 | N/A |
| 9/30/2014 | 10,781 | 621 | N/A | 2,173 | N/A |
| 6/30/2014 | 10,765 | 1,137 | N/A | 2,603 | N/A |
| 3/31/2014 | 10,744 | 1,392 | N/A | 2,850 | N/A |
| 12/31/2013 | 10,724 | 1,647 | N/A | 3,097 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: 3983Das prognostizierte Gewinnwachstum (4.3% pro Jahr) liegt über der Sparquote (2.3%).
Ertrag vs. Markt: 3983Die Erträge des Unternehmens (4.3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Hong Kong (11.7% pro Jahr).
Hohe Wachstumserträge: 3983Die Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: 3983Die Einnahmen des Unternehmens (2.1% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Hong Kong (7.8% pro Jahr).
Hohe Wachstumseinnahmen: 3983Die Einnahmen des Unternehmens (2.1% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: 3983Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (7%).